2 completed, 1 recruiting, 1 terminated, 1 unknown. 2 Phase 2, 2 Phase 4, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Phase 4 | 2 | Completed 1, Unknown 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow OM-85: new trials by email Literature Review of OM-85 trials Research Report on OM-85
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Efficacy and Safety of Daily OM-85 in Young Children With Recurrent Wheezing OM-85, Placebo - Recurrent Wheezing, Wheezing Lower Respiratory Illness | Phase 2 | Completed | OM Pharma SA | 296 | 2023-06-20 | 2026-10-16 |
| OM-85 in Paediatric Recurrent Respiratory Tract Infections With Wheezing Lower Respiratory Illness OM-85, Placebo - Respiratory Tract Infections, Wheezing Lower Respiratory Illness | Phase 4 | Completed | OM Pharma SA | 525 | 2022-12-12 | 2026-09-25 |
| Protecting Preterm Infants From Respiratory Tract Infections and Wheeze by Using Bacterial Lysates. Broncho-Vaxom, Placebo - Wheezing, LRTI | Phase 3 | Recruiting | Franciscus Gasthuis | 500 | 2022-03-18 | 2026-09-25 |
| Immunomodulation by OM-85 (Broncho-Vaxom) in Early AD Broncho-Vaxom, Placebo - Atopic Dermatitis | Phase 2 | Terminated | OM Pharma SA | 63 | 2021-12-20 | 2023-08-08 |
| Effect of OM-85 on Respiratory Tract Infections and Adenoid Tissue in Children With Adenoid Hypertrophy OM-85, Placebo - Adenoid Hypertrophy, Adenoid Hyperplasia | Phase 4 | Unknown | Dr. Sami Ulus Children's Hospital | 68 | 2017-11-01 | 2017-10-05 |
Respiratory Tract Infections (3) · Respiratory Sounds (2) · Dermatitis, Atopic (1) · Lymphoma, Follicular (1) · Premature Birth (1)
OM Pharma SA (3) · Dr. Sami Ulus Children's Hospital (1) · Franciscus Gasthuis (1)
Poland (3) · Germany (2) · Hungary (2) · Netherlands (2) · Australia (1) · France (1) · Italy (1) · Switzerland (1) · United Kingdom (1) · United States (1)
Franziska Rueff, Professor (1) · Serap Ozmen (1)